{"id":"W2061436092","doi":"10.3109/09546634.2011.643221","title":"A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne","year":2011,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"XLV Diagnostics (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Benzoyl peroxide; Quality of life (healthcare); Patient satisfaction; Randomized controlled trial; Regimen; Acne treatment; Dermatology Life Quality Index; Combination therapy; Minimal clinically important difference; Dermatology; Internal medicine; Physical therapy; Surgery; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002845326,0.0003443529,0.0008028888,0.0002412574,0.0001390298,0.0003272038,0.0003654207,0.000306944,0.003240109],"category_scores_gemma":[0.0003084416,0.0001568453,0.0003523796,0.0001825824,0.0002045155,0.0002569822,0.0001631565,0.0007295666,0.0003750235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000122217,"about_ca_system_score_gemma":0.0001928519,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002431111,"about_ca_topic_score_gemma":0.0005887033,"domain_scores_codex":[0.9998437,0.00004934983,0.00001041965,0.00003043427,0.00003267618,0.00003339068],"domain_scores_gemma":[0.9998869,0.00003010209,0.00002872698,0.00001286378,0.000008416177,0.00003296739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0853316,0.02883525,0.003589484,0.001463394,0.0004744207,0.0001508785,0.0001211656,0.001280632,0.6656017,0.0002117376,0.001011846,0.2119279],"study_design_scores_gemma":[0.07638132,0.5875842,0.09717696,0.0002215988,0.001322412,0.001125231,0.0002081258,0.004036061,0.2189917,0.0002772035,0.0125862,0.00008901935],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971563,0.001703966,0.000368384,0.00005728441,0.00003583359,0.0001148494,0.00007223357,0.00003490453,0.0004563927],"genre_scores_gemma":[0.9974717,0.0008767885,0.0006637005,0.00004042629,0.00004857465,0.0001084726,0.0001040643,0.000007494776,0.000678753],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003240109,"threshold_uncertainty_score":0.01083922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04547356424103866,"score_gpt":0.2971984006147316,"score_spread":0.2517248363736929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}